Posted by Michael Wonder on 13 Dec 2025
More efficacious dose of Wegovy recommended by the EMA can help people with obesity achieve an average of 20.7% weight loss
12 December 2025 - In the STEP UP programme, people with obesity taking Wegovy 7.2 mg lost an average of 20.7% body weight at 72 weeks; one in three people achieved 25% or more weight loss.
Today, the EMA's CHMP issued a positive opinion for a higher dose of Wegovy (semaglutide 7.2 mg), bringing it a step closer to offering individuals with obesity in the EU a new Wegovy option for even greater weight loss.
